Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa.
Boris K TchoungaCharlotte CharpentierPatrick A CoffieFrançois DabisDiane DescampsSerge P EholieDidier K EkoueviPublished in: PloS one (2020)
The 36-months survival rate among ART-experienced HIV-2 patients with drug-resistant viruses is below 70%,lower than in HIV-1. There is urgent need to improve access to second-line ART for patients living with HIV-2 in West Africa.
Keyphrases
- hiv infected
- antiretroviral therapy
- drug resistant
- hiv positive
- human immunodeficiency virus
- end stage renal disease
- hiv aids
- hepatitis c virus
- newly diagnosed
- ejection fraction
- chronic kidney disease
- hiv infected patients
- multidrug resistant
- prognostic factors
- acinetobacter baumannii
- patient reported outcomes
- south africa
- free survival
- patient reported